KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Share-based Compensation: 2009-2024

Historic Share-based Compensation for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to $214.9 million.

  • Exact Sciences' Share-based Compensation rose 5.88% to $51.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $211.2 million, marking a year-over-year decrease of 5.81%. This contributed to the annual value of $214.9 million for FY2024, which is 7.10% down from last year.
  • As of FY2024, Exact Sciences' Share-based Compensation stood at $214.9 million, which was down 7.10% from $231.3 million recorded in FY2023.
  • Exact Sciences' Share-based Compensation's 5-year high stood at $253.1 million during FY2021, with a 5-year trough of $152.9 million in FY2020.
  • Moreover, its 3-year median value for Share-based Compensation was $214.9 million (2024), whereas its average is $217.7 million.
  • Per our database at Business Quant, Exact Sciences' Share-based Compensation skyrocketed by 65.50% in 2021 and then dropped by 18.27% in 2022.
  • Exact Sciences' Share-based Compensation (Yearly) stood at $152.9 million in 2020, then surged by 65.50% to $253.1 million in 2021, then declined by 18.27% to $206.8 million in 2022, then grew by 11.84% to $231.3 million in 2023, then fell by 7.10% to $214.9 million in 2024.